Scientific reports · 2025
Stroma and lymphocytes identified by deep learning are independent predictors for survival in pancreatic cancer.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tan Xiuxiang, Rosin Mika, Appinger Simone, Deierl Julia Campello, Reichel Konrad, Coolsen Mariëlle, Valkenburg-van Iersel Liselot, de Vos-Geelen Judith, de Jong Evelien J M, Bednarsch Jan, Grootkoerkamp Bas, Doukas Michail, van Eijck Casper, Luedde Tom, Dahl Edgar, Kather Jakob Nikolas, Sivakumar Shivan, Knoefel Wolfram Trudo, Wiltberger Georg, Neumann Ulf Peter, Heij Lara R
Аннотация
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers known to humans. However, not all patients fare equally poor survival, and a minority of patients even survives advanced disease for months or years. Thus, there is a clinical need to search corresponding prognostic biomarkers which forecast survival on an individual basis. To dig more information and identify potential biomarkers from PDAC pathological slides, we trained a deep learning (DL) model based U-net-shaped backbone. This DL model can automatically detect tumor, stroma and lymphocytes on whole slide images (WSIs) of PDAC patients. We performed an analysis of 800 PDAC scans, categorizing stroma in percentage (SIP) and lymphocytes in percentage (LIP) into two and three categories, respectively. The presented model achieved remarkable accuracy results with a total accuracy of 94.72%, a mean intersection of union rate of 78.66%, and a mean dice coefficient of 87.74%. Survival analysis revealed that SIP-mediate and LIP-high groups correlated with enhanced median overall survival (OS) across all cohorts. These findings underscore the potential of SIP and LIP as prognostic biomarkers for PDAC and highlight the utility of DL as a tool for PDAC biomarkers detecting on WSIs.